Stockscreener 앱 받기
44.25
0.32%
0.14
시간 외 거래:
44.30
0.05
+0.11%
전일 마감가:
$44.11
열려 있는:
$44.11
하루 거래량:
1.63M
Relative Volume:
0.57
시가총액:
$105.92B
수익:
$49.41B
순이익/손실:
$5.59B
주가수익비율:
18.53
EPS:
2.3875
순현금흐름:
$8.32B
1주 성능:
-1.71%
1개월 성능:
+3.24%
6개월 성능:
-9.10%
1년 성능:
-12.95%
1일 변동 폭
$44.02
$44.51
1주일 범위
$43.35
$44.85
52주 변동 폭
$42.28
$52.68
사노피 ADR Stock (SNY) Company Profile
Compare SNY vs LLY, JNJ, ABBV, MRK, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNY
Sanofi Adr
|
44.25 | 105.92B | 49.41B | 5.59B | 8.32B | 2.3875 |
LLY
Lilly Eli Co
|
1,133.00 | 1.01T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
240.87 | 579.83B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
227.73 | 402.35B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
119.05 | 294.03B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
153.07 | 292.07B | 54.66B | 13.58B | 16.05B | 7.0171 |
사노피 ADR Stock (SNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-20 | 다운그레이드 | BNP Paribas Exane | Outperform → Neutral |
| 2026-02-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2026-01-27 | 개시 | Citigroup | Neutral |
| 2026-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2026-01-06 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-12-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-12-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-08-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-04-15 | 개시 | Exane BNP Paribas | Outperform |
| 2025-03-21 | 개시 | Goldman | Neutral |
| 2025-01-30 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-07-26 | 재확인 | Argus | Buy |
| 2024-01-23 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-01-16 | 재개 | UBS | Buy |
| 2023-12-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-10-30 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-09-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-28 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-03-27 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-12-13 | 재개 | Morgan Stanley | Overweight |
| 2022-08-12 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-08-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-09-27 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-01-15 | 개시 | Deutsche Bank | Sell |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-03-17 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-03-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-02-11 | 개시 | SVB Leerink | Mkt Perform |
| 2020-01-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-03 | 개시 | Bernstein | Outperform |
| 2019-08-14 | 업그레이드 | UBS | Neutral → Buy |
| 2018-12-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-11-01 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-10-09 | 개시 | Guggenheim | Neutral |
| 2018-09-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-08-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-03-23 | 업그레이드 | Liberum | Hold → Buy |
| 2018-01-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2017-12-06 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-12-01 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2017-11-15 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2017-08-30 | 업그레이드 | HSBC Securities | Reduce → Hold |
모두보기
사노피 ADR 주식(SNY)의 최신 뉴스
Sanofi S.A. Stock (FR0000120578): FDA accelerated approval for Tzield puts diabetes franchise in foc - AD HOC NEWS
Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3 - GlobeNewswire Inc.
Sanofi S.A. Stock (FR0000120578): Valuation Metrics Under the Microscope - AD HOC NEWS
Sanofi S.A. Stock (FR0000127771): Stock in focus as no fresh trigger is verified - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Diabetes focus and pipeline news keep Big Pharma in motion - AD HOC NEWS
European ADRs Started The Week In The Green - Finimize
Sanofi S.A. stock (FR0000127771): diabetes deal and pipeline focus move into the spotlight - AD HOC NEWS
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sahm
Senior Chinese legislator meets Myanmar's foreign minister - news.cgtn.com
Sanofi (SASY) Stock: Pharma Giant Launches AI Sales Agent Built on Snowflake - MEXC
SNY Stock Price, Quote & Chart | SANOFI-ADR (NASDAQ:SNY) - ChartMill
Sanofi S.A. stock (FR0000120578): analyst consensus steady as ADRs trade in low-40s USD range - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Analyst consensus points to hold stance as shares hover in low-40s - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Technical picture and price action on Euronext Paris - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Vaccine and obesity focus after Q1 2026 earnings - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 results, pipeline focus and outlook for US investors - AD HOC NEWS
SANOFI-ADR (NASDAQ:SNY): A Quality Dividend Stock with a 5.31% Yield and Strong Fundamentals - ChartMill
Publicis Groupe stock (FR0000120578): LiveRamp deal and AI push keep investors focused - AD HOC NEWS
Publicis Groupe S.A. stock (FR0000120578): LiveRamp deal and AI push reshape data strategy - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): EU green light for multiple myeloma drug Sarclisa draws investor f - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Vaccine unit and new drug launches keep investors alert - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 beat and pipeline focus keep investors watching - AD HOC NEWS
Sanofi stock (FR0000120578): Pipeline updates keep investors watching - AD HOC NEWS
Sanofi stock (FR0000120578): trial data and EU approval updates - AD HOC NEWS
Sanofi stock (FR0000120578): Dupixent data and AI investment keep focus on growth - AD HOC NEWS
Sanofi stock (FR0000120578): FDA, dividend and Dupixent keep investors focused - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Q1 figures, GLP-1 hopes and focus on pipeline value - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 2026 results reviewed - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Global pharma leader's business and market position - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Recent earnings and pipeline updates - AD HOC NEWS
Sanofi (NASDAQ:SNY) Emerges as a Decent Value Pick with Strong Fundamentals - ChartMill
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1 - ChartMill
European ADRs Open The Week Lower In US Trading - Finimize
Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - GlobeNewswire Inc.
FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat - Sahm
Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision - Sahm
Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises - Investing.com
Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises By Investing.com - Investing.com Canada
사노피 ADR (SNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
0.22%
자본화:
|
볼륨(24시간):